CA09073K1084
© Newsfile
18.10.2021
BUX
LISTED
CSE
Liquid Biopsy Company BioMark to Present at the 3rd Annual Congress of the International Society of Liquid Biopsy to Be Held October 22, 2021
News Preview
Vancouver, British Columbia--(Newsfile Corp. - October 18, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce that it will hold a virtual stand at the III annual Congress of the International Society...
Themefolio
Profiler
Peergroup
© Newsfile
29.06.2021
BUX
LISTED
CSE
Biomark to Expand Treatment Response Trial to Advanced Lung Cancer Patients Receiving Immunotherapy
News Preview
Vancouver, British Columbia--(Newsfile Corp. - June 29, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce that Health Canada has approved its clinical trial application (CTA) and has granted a Letter of No Objection (NOL) for its application entitled Excretion of Acetylamantadine (AA)...
Themefolio
Profiler
Peergroup
© Newsfile
01.06.2021
BUX
LISTED
CSE
BioMark Receives $825K Grant to Develop Its Liquid Biopsy Assay for Lung Cancer Screening
News Preview
Vancouver, British Columbia--(Newsfile Corp. - June 1, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce today that its wholly-owned subsidiary BioMark Diagnostic Solutions Inc. ("BDS") received funding to develop an early-stage lung cancer screening assay using BioMark's proprietary liquid...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Newsfile
01.06.2021
BUX
LISTED
CSE
BioMark reçoit une subvention de 825 000 $ pour développer son test de biopsie liquide pour le dépistage du cancer du poumon
News Preview
Vancouver, British Columbia--(Newsfile Corp. - 1 juin 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) («BioMark») est heureuse d'annoncer aujourd'hui que sa filiale en propriété exclusive BioMark Diagnostic Solutions Inc. ("BDS") a reçu un financement pour le développement d'un test de dép...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Newsfile
31.05.2021
BUX
LISTED
CSE
BioMark Announces Change of Auditor
News Preview
Vancouver, British Columbia--(Newsfile Corp. - May 31, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") announces that it has changed its auditors from Manning Elliott LLP ("Former Auditor") to PricewaterhouseCoopers LLP ("Successor Auditor"). The Former Auditor resigned as the auditor of the Company effect...
Themefolio
Profiler
Peergroup
© Newsfile
29.04.2021
BUX
LISTED
CSE
Biomark to Open a Diagnostic Laboratory in Quebec
News Preview
Vancouver, British Columbia--(Newsfile Corp. - April 29, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce today that its wholly-owned subsidiary BioMark Diagnostic Solutions Inc. ("BDS") will be operating a diagnostic laboratory in Quebec, Canada, which will primarily serve to advance the...
Themefolio
Profiler
Peergroup
© Newsfile
21.04.2021
BUX
LISTED
CSE
BioMark Announces Exercise of Warrants and Gain DTC Eligibility for Its Common Shares
News Preview
Vancouver, British Columbia--(Newsfile Corp. - April 21, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce today the agreement by several long-time strategic accredited investors and insiders to exercise approximately 2,000,000 warrants issued in connection with the Company's private p...
Themefolio
Profiler
Peergroup
© Newsfile
16.03.2021
BUX
LISTED
CSE
Biomark's Collaborator Receives Funding to Validate Its Biomarker Panel for the Early Detection of Lung Cancer
News Preview
Vancouver, British Columbia--(Newsfile Corp. - March 16, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce today that its sponsored research collaboration with The Metabolomics Innovation Centre (TMIC) was successful in receiving funding from the Novel Technology Application in Cancer...
Themefolio
Profiler
Peergroup
© Newsfile
02.03.2021
BUX
LISTED
CSE
BioMark Grants Options
News Preview
Vancouver, British Columbia--(Newsfile Corp. - March 2, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce that it has granted 2,100,000 incentive stock options under the Company's Stock Option Plan ("Option Plan") to third-party consultants to support market communication and corporate strat...
Themefolio
Profiler
Peergroup
© Newsfile
16.02.2021
BUX
LISTED
CSE
BioMark and Phytronix Technologies Inc. Enter into a Collaborative Research and Development Agreement
News Preview
Vancouver, British Columbia--(Newsfile Corp. - February 16, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce that its wholly-owned subsidiary BioMark Diagnostic Solutions Inc. has entered into a collaborative research and development agreement with Phytronix Technologies Inc. ("Phytronix")...
Themefolio
Profiler
Peergroup
© Newsfile
08.02.2021
BUX
LISTED
CSE
BioMark Diagnostics Targets Response to Treatment Application with Its Liquid Biopsy Platform
News Preview
Vancouver, British Columbia--(Newsfile Corp. - February 8, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce that the article "Use of Amantadine in the Evaluation of Response to Chemotherapy in Lung Cancer - a Pilot Study" has been published in the peer-reviewed journal Future Science OA.Ras...
Themefolio
Profiler
Peergroup
© Newsfile
11.01.2021
BUX
LISTED
CSE
Alfred Berkeley Joins BioMark's Advisory Team
News Preview
Vancouver, British Columbia--(Newsfile Corp. - January 11, 2021) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark") is glad to announce Alfred Berkeley as a new member of the BioMark's Advisory team, as he will be providing strategic and financial advice to help expand the company's commercialization effort in the U.S.Mr. R...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
07.12.2020
BUX
LISTED
CSE
BioMark Retains Questrade, Inc. to Provide Market-Making Services
News Preview
Vancouver, British Columbia--(Newsfile Corp. - December 7, 2020) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") announced today that it has retained Questrade, Inc. ("Questrade") to provide market-making services in accordance with CSE guidelines.The term of the agreement is for one year, beginning December 7, 2...
Themefolio
Profiler
Peergroup
© Newsfile
23.09.2020
BUX
LISTED
CSE
BioMark Scientific Advisor Dr. Donald Miller to Present at the Delaware Valley Drug Metabolism Discussion Group
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 23, 2020) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce that on September 29, its strategic scientific advisor Dr. Donald Miller is to present on BioMark's SSAT amantadine assay for the early detection of cancer at the prestigious Delawa...
Themefolio
Profiler
Peergroup
© Newsfile
16.09.2020
BUX
LISTED
CSE
BioMark Appoints Dr. Jean-Francois Haince as Strategic Advisor to Guide Its Expansion into Quebec
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 16, 2020) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce that it has appointed Dr. Jean-Francois (Jeff) Haince as a strategic advisor to its management team. Rashid Ahmed, President and CEO, says, "We are delighted to welcome Dr. Haince i...
Themefolio
Profiler
Peergroup
© Newsfile
14.09.2020
BUX
LISTED
CSE
BioMark Team Invited for Full Application for Sparks Grant Competition
News Preview
Vancouver, British Columbia--(Newsfile Corp. - September 14, 2020) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce that 2 of its most recent abstract submissions for the Novel Technology Application in Cancer Prevention and Early Detection Spark Grants competition have resulted in invitations t...
Themefolio
Profiler
Peergroup
© Newsfile
27.08.2020
BUX
LISTED
CSE
BioMark Team Secures Health Canada Letter of No Objection for Its Glioblastoma Clinical Trial
News Preview
Vancouver, British Columbia--(Newsfile Corp. - August 27, 2020) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce that Health Canada has approved its clinical trial application (CTA) and has granted a Letter of No Objection (NOL) for its application entitled ACETYL-AMANTADINE AS A BIOMARKER...
Themefolio
Profiler
Peergroup
© Newsfile
13.08.2020
BUX
LISTED
CSE
BioMark Diagnostics Expands Research Development in Quebec
News Preview
Vancouver, British Columbia--(Newsfile Corp. - August 13, 2020) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark"), a developer of proprietary, non-invasive, and accurate diagnostic solutions announced today that the Company is moving parts of its lung cancer research and development operations to LE CAMP, an incubator-...
Themefolio
Profiler
Peergroup
© Newsfile
21.07.2020
BUX
LISTED
CSE
BioMark's Affiliated Company, Bio-Stream Diagnostics Inc. Announces Partnership with Qatar University ML Team for Development of COVID-19 Testing
News Preview
The Company will leverage Raman spectroscopy and Machine Learning as part of its diagnosticsVancouver, British Columbia--(Newsfile Corp. - July 21, 2020) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") announced today that its affiliated company, Bio-Stream Diagnostics Inc., will be working with University of Qatar's...
Themefolio
Profiler
Peergroup
© Newsfile
16.07.2020
BUX
LISTED
CSE
BioMark Diagnostics Inc. Receives Full Registered Trademark Status from the US Patent and Trademark Office for its Company Brand Name "BioMark"
News Preview
Vancouver, British Columbia--(Newsfile Corp. - July 16, 2020) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") announced today that the Company has been granted a Full Registered Trademark Status from the US Patent and Trademark Office for its Company Brand Name "BioMark". The term "BioMark" was selected by the...
Themefolio
Profiler
Peergroup
© Newsfile
23.06.2020
BUX
LISTED
CSE
BioMark Diagnostics Announces Peer Reviewed Publication on Detection of Cancer
News Preview
Vancouver, British Columbia--(Newsfile Corp. - June 23, 2020) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark"), a developer of proprietary, non-invasive, and accurate cancer diagnostic solutions to assist in detecting, monitoring and assessing treatment for cancer early and cost effectively, announced today a peer rev...
Themefolio
Profiler
Peergroup
© Newsfile
18.06.2020
BUX
LISTED
CSE
BioMark Receives European Patent for Cancer Diagnostic
News Preview
Vancouver, British Columbia--(Newsfile Corp. - June 18, 2020) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") announced today that the company has been granted a patent titled "A METHOD FOR ASSAYING THE ACTIVITY OF SPERMIDINE/SPERMINE N1-ACETYLTRANSFERASE." The method comprises correlating a presence of the acetylat...
Themefolio
Profiler
Peergroup
© Newsfile
16.06.2020
BUX
LISTED
CSE
Bio Stream Diagnostics Inc. Selected for CDL Rapid Response Innovation Program
News Preview
Vancouver, British Columbia--(Newsfile Corp. - June 16, 2020) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark") is pleased to announce that its affiliated company, Bio Stream Diagnostics Inc., was selected to participate in the global academic science and tech startup program Creative Destruction Lab's (CDL) recent de...
Themefolio
Profiler
Peergroup
© Newsfile
11.06.2020
BUX
LISTED
CSE
BioMark Diagnostics Inc. Clarifies Prior Disclosure
News Preview
Vancouver, British Columbia--(Newsfile Corp. - June 11, 2020) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark"), a developer of proprietary, non-invasive, and accurate diagnostic solutions which can help detect, monitor and assess cancer early and cost effectively, wishes to include additional information to clarify th...
Themefolio
Profiler
Peergroup
© Newsfile
10.06.2020
BUX
LISTED
CSE
BioMark Diagnostics Forms New Company, Bio Stream Diagnostics Inc., for '30-Second' COVID-19 Screening
News Preview
Rapid COVID-19 testing will use machine learning and advanced Raman spectroscopy to provide low-cost, accurate resultsVancouver, British Columbia--(Newsfile Corp. - June 10, 2020) - BioMark Diagnostics Inc.(CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark"), a developer of proprietary, non-invasive, and accurate diagnostic solutions which can help...
Themefolio
Profiler
Peergroup
© Newsfile
24.03.2020
BUX
LISTED
CSE
BioMark's Liquid Biopsy Assay Levering Metabolomics Demonstrates Strong Performance for Early Lung Cancer Detection
News Preview
Vancouver, British Columbia--(Newsfile Corp. - March 24, 2020) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC PINK: BMKDF) ("BioMark") is pleased to announce that the article "A High-Performing Plasma Metabolite Panel for Early-Stage Lung Cancer Detection" has been published in the peer-reviewed journal Cancers, validating BioMark's te...
Themefolio
Profiler
Peergroup
© Newsfile
16.03.2020
BUX
LISTED
CSE
BioMark Diagnostics Advanced Raman Spectrometer Could Potentially Serve as Complementary Detection Tool for COVID -19 / Coronavirus
News Preview
Originally created as part of the company's cancer ultra sensitive and small molecule specific detection system, the device has potential to identity many infectious diseasesVancouver, British Columbia--(Newsfile Corp. - March 16, 2020) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) ("BioMark"), a developer of proprietary, non-i...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
